ROLONTIS Trademark

Trademark Overview

On Wednesday, December 7, 2016, a trademark application was filed for ROLONTIS with the United States Patent and Trademark Office. The USPTO has given the ROLONTIS trademark a serial number of 87260340. The federal status of this trademark filing is REGISTERED as of Tuesday, March 6, 2018. This trademark is owned by Spectrum Pharmaceuticals, Inc.. The ROLONTIS trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF CANCER AND RELATED SYMPTOMS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF NEUTROPENIA
rolontis

General Information

Serial Number87260340
Word MarkROLONTIS
Filing DateWednesday, December 7, 2016
Status700 - REGISTERED
Status DateTuesday, March 6, 2018
Registration Number5419341
Registration DateTuesday, March 6, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF CANCER AND RELATED SYMPTOMS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF NEUTROPENIA

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 12, 2016
Primary Code005
First Use Anywhere DateThursday, December 14, 2017
First Use In Commerce DateThursday, December 14, 2017

Trademark Owner History

Party NameSpectrum Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
Party NameSpectrum Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHenderson, NV 89052
Party NameSpectrum Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHenderson, NV 89052

Trademark Events

Event DateEvent Description
Wednesday, January 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 17, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 4, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 4, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 4, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 4, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 4, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 6, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, January 30, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, January 27, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 4, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, December 18, 2017USE AMENDMENT FILED
Thursday, January 4, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 18, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 10, 2017ASSIGNED TO EXAMINER
Monday, December 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 10, 2016NEW APPLICATION ENTERED

Related Keywords

rolontis pharmaceutical treatment preparations neutropenia symptoms cancer prevention related